Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNMD | Common Stock | Options Exercise | $165K | +5K | +18.52% | $32.93 | 32K | Apr 28, 2023 | Direct | |
transaction | CNMD | Common Stock | Tax liability | $0 | -2.64K | -8.26% | $0.00 | 29.4K | Apr 28, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNMD | Sars (Stock Appreciation Rights) | Options Exercise | $0 | -5K | -100% | $0.00* | 0 | Apr 28, 2023 | Common Stock | 5K | $32.93 | Direct | F1 |
Id | Content |
---|---|
F1 | The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |